A Phase II clinical study of HL036 for dry eye disease.
Phase of Trial: Phase II
Latest Information Update: 13 Sep 2017
At a glance
- Drugs HL 036 (Primary)
- Indications Dry eyes
- Focus Therapeutic Use
- 13 Sep 2017 New trial record
- 12 Sep 2017 According to a HanAll Biopharma media release, company has submitted an Investigational New Drug (IND) application to initiate this study in November 2017.